<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7194560\results\search\testTrace\results.xml">
  <result pre="SciLife SciLife Sciences0024-32051879-0631Elsevier Inc. S0024-3205(20)30375-1 doi: 10.1016/j.lfs.2020.117627117627 : Article Virtual" exact="screening" post="and repurposing of FDA approved drugs against COVID-19 main"/>
  <result pre="COVID-19 crystal structure (main protease) was targeted in a virtual" exact="screening" post="study by of FDA approved drugs dataset. In addition,"/>
  <result pre="sequence comparisons, respectively. The top 20 drugs in the virtual" exact="screening" post="studies comprised a broad-spectrum antiviral (ribavirin), anti-hepatitis B virus"/>
  <result pre="CoV (SARS CoV) was evolved [2]. The source of the" exact="infection" post="was recorded from animal origins, including a bat as"/>
  <result pre="concerns [5,6]. Lastly, COVID-19 emerged in Wuhan, China. The first" exact="isolation" post="was related to an animal market and human-to-human transmission"/>
  <result pre="2020 (PDB ID 6lu7). In this study, the first virtual" exact="screening" post="study against the first known COVID-19 was performed. The"/>
  <result pre="using OPLS2005 force field. 2.5 COVID-19 Mpro protein preparation Virtual" exact="screening" post="was implemented by using the published crystal structure of"/>
  <result pre="center for docking box of 20Â Ã… size. 2.6 Virtual" exact="screening" post="The Schrodinger glide docking module was used for virtual"/>
  <result pre="docking score curcumin. 3 Results and discussion Molecular modeling, virtual" exact="screening" post="and other computational techniques are widely used methods to"/>
  <result pre="during drug discovery process [[14], [15], [16], [17], [18]]. Virtual" exact="screening" post="has been used in drug discovery against emerging and"/>
  <result pre="96.08 153 MERS CoV 51.61 50.65 The results of virtual" exact="screening" post="of FDA approved drugs against COVID-Mpro is presented in"/>
  <result pre="Ribavirin is officially approved for treating respiratory syncytial virus (RSV)" exact="infection" post="and, in combination with interferon Î±2b for hepatitis C"/>
  <result pre="of telbivudine in this study suggests its repurposing for COVID-19" exact="treatment" post="by its binding to Mpro. In comparison with curcumin,"/>
  <result pre="SER49 and GLV189 (Fig. 2D and E). Fig. 2 Virtual" exact="screening" post="and docking of FDA drugs with COVID-19 Mpro. A)"/>
  <result pre="was more phylogenetically related to SARS Mpro. After a virtual" exact="screening" post="capmain against COVID-19 Mpro, a set of antivirals, vitamins,"/>
  <result pre="falciparum TMP kinase. Implications for drug discoveryParasitology1362009112519126267 17MurgueitioM.S.BermudezM.MortierJ.WolberG.In silico virtual" exact="screening" post="approaches for anti-viral drug discoveryDrug Discov. Today Technol.92012(e219-e25) 18SheikhA.Al-TaherA.Al-NazawiM.Al-MubarakA.I.KandeelM.Analysis"/>
  <result pre="vaccine designJ. Virol. Methods2772020113806 19LiuB.ZhouJ.SARS-CoV protease inhibitors design using virtual" exact="screening" post="method from natural products librariesJ. Comput. Chem.26200548449015693056 20SiroisS.WeiD.-Q.DuQ.ChouK.-C.Virtual screening"/>
  <result pre="virtual screening method from natural products librariesJ. Comput. Chem.26200548449015693056 20SiroisS.WeiD.-Q.DuQ.ChouK.-C.Virtual" exact="screening" post="for SARS-CoV protease based on KZ7088 pharmacophore pointsJ. Chem."/>
  <result pre="on KZ7088 pharmacophore pointsJ. Chem. Inf. Comput. Sci.4420041111112215154780 21ElHefnawiM.ElGamacyM.FaresM.Multiple virtual" exact="screening" post="approaches for finding new Hepatitis c virus RNA-dependent RNA"/>
  <result pre="pharmacological inhibitorsBMC Bioinf. BioMed Central2012S5 22ZhouZ.KhaliqM.SukJ.-E.PatkarC.LiL.KuhnR.J.Antiviral compounds discovered by virtual" exact="screening" post="of smallâˆ’ molecule libraries against dengue virus E proteinACS"/>
  <result pre="proteins associated with Ebola virus: in silico discovery using virtual" exact="screening" post="and molecular docking studiesInterdiscip. Sci. Comput. Life Sci.82016132141 24CrottyS.MaagD.ArnoldJ.J.ZhongW.LauJ.Y.HongZ.The"/>
  <result pre="ribavirin is an RNA virus mutagenNat. Med.620001375137911100123 25KorenG.KingS.KnowlesS.PhillipsE.Ribavirin in the" exact="treatment" post="of SARS: a new trick for an old drug?CMAJ16820031289129212743076"/>
 </snippets>
</snippetsTree>
